- Home
- CISO vs ADXN Comparison
CISO vs ADXN Comparison
Compare CISO & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- ADXN
- Stock Information
- Founded
- CISO 2015
- ADXN 2002
- Country
- CISO United States
- ADXN Switzerland
- Employees
- CISO N/A
- ADXN N/A
- Industry
- CISO Computer Software: Prepackaged Software
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- CISO Technology
- ADXN Health Care
- Exchange
- CISO Nasdaq
- ADXN Nasdaq
- Market Cap
- CISO 44.2M
- ADXN 8.7M
- IPO Year
- CISO N/A
- ADXN N/A
- Fundamental
- Price
- CISO $0.81
- ADXN $8.02
- Analyst Decision
- CISO
- ADXN Strong Buy
- Analyst Count
- CISO 0
- ADXN 1
- Target Price
- CISO N/A
- ADXN $30.00
- AVG Volume (30 Days)
- CISO 6.3M
- ADXN 1.7K
- Earning Date
- CISO 05-15-2025
- ADXN 06-09-2025
- Dividend Yield
- CISO N/A
- ADXN N/A
- EPS Growth
- CISO N/A
- ADXN N/A
- EPS
- CISO N/A
- ADXN 0.08
- Revenue
- CISO $29,887,603.00
- ADXN $452,495.00
- Revenue This Year
- CISO N/A
- ADXN $86.57
- Revenue Next Year
- CISO N/A
- ADXN N/A
- P/E Ratio
- CISO N/A
- ADXN $0.91
- Revenue Growth
- CISO N/A
- ADXN N/A
- 52 Week Low
- CISO $0.26
- ADXN $6.51
- 52 Week High
- CISO $3.84
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- CISO 43.69
- ADXN 49.55
- Support Level
- CISO $0.97
- ADXN $7.57
- Resistance Level
- CISO $1.49
- ADXN $8.38
- Average True Range (ATR)
- CISO 0.29
- ADXN 0.07
- MACD
- CISO -0.04
- ADXN -0.06
- Stochastic Oscillator
- CISO 14.42
- ADXN 48.39
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.